Stocks in Focus: ACME Solar, Titagarh Rail, and Others

The GIFT Nifty futures, which are an early indicator of the Nifty50 index stocks, were trading lower by 91 points at 22,966, indicating that the domestic benchmark indices are likely to make a negative start on Tuesday. 

Earlier on Monday, 6 April, the domestic benchmark indices S&P BSE Sensex surged by 787 points or 1.07%, and settled at 74,106, while the Nifty50 traded 1.12% higher or 255 points, closing at 22,968.

Here are some stocks that are likely to remain in focus on 7 April.

ACME Solar Holdings: The company, through its subsidiary ACME Suryodaya, commissioned the fifth phase of 76 MW / 160.512 MWh from its total 285 MW / 601.904 MWh Battery Energy Storage System (BESS) project in Jaisalmer, Rajasthan, taking the commissioned capacity to 247 MW / 521.652 MWh.

Titagarh Rail Systems: The company’s subsidiary, Titagarh Naval Systems, secured in-principle approval from the Ministry of Ports, Shipping and Waterways for a Rs 610 crore brownfield expansion project at Falta, West Bengal, under the Government of India’s Shipbuilding Development Scheme (SbDS).

PDS: The company entered into a Sourcing-as-a-Service (SaaS) agreement with a leading US-based value retailer. Under this contract, PDS will deliver end-to-end sourcing support using its global network across vendor management, compliance, and supply chain execution. The deal is expected to generate sourcing volumes of around Rs 450 crore, with scope for gradual scaling.

Deep Industries: The company received a Letter of Award from Oil and Natural Gas Corporation for providing services related to natural gas compression, gas dehydration, and hydrocarbon dew point depression at Malleswaram in ONGC’s Rajahmundry Asset for three years, with an estimated contract value of Rs 59 crore.

Aurobindo Pharma: The company’s subsidiary, CuraTeQ Biologics, reported positive topline results from its Phase 3 study of BP11, a proposed biosimilar to Xolair (omalizumab). The study met all primary endpoints and demonstrated strong comparability with the reference product in patients with chronic spontaneous urticaria (CSU) at the 300 mg dose.

Unlock profitable opportunities every day! Tradz by EquityPandit provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Tradz by EquityPandit and start winning now!

The post Stocks in Focus: ACME Solar, Titagarh Rail, and Others appeared first on Equitypandit.